EPAC 241220 45.00P (EPAC241220P45000) Stock Options, News & Quotes

1.00
+0.60+150.00%

15min DelayTrading Dec 20 09:30 ET

1.00High1.00Low

SymbolStock Name

PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

Moomoo AI

Mar 5 07:02

Enerpac Tool Group's rapid EPS growth and large insider investment make it an attractive investment. Its strong financial performance indicates a potential opportunity. However, investors should note the company's 1 warning sign.

If EPS Growth Is Important To You, Enerpac Tool Group (NYSE:EPAC) Presents An Opportunity

Moomoo AI

Feb 15 06:53

Enerpac Tool Group's impressive ROCE trend suggests a turnaround with higher returns on lower capital. However, investors may not fully recognize these promising fundamentals, indicating potential for further stock research.

Investors Shouldn't Overlook Enerpac Tool Group's (NYSE:EPAC) Impressive Returns On Capital

Moomoo AI

Dec 19, 2023 05:33

Enerpac's high P/E ratio echoes its superior future earnings outlook, convincing shareholders to hold onto their stocks. Despite some industry debates, P/E ratio remains a strong business sentiment marker.

Enerpac Tool Group Corp.'s (NYSE:EPAC) P/E Is On The Mark

Moomoo AI

Nov 15, 2023 05:17

Enerpac Tool Group's rapid EPS growth and significant insider ownership mark it as a company to watch. Yet, investors should also consider potential risks.

Here's Why Enerpac Tool Group (NYSE:EPAC) Has Caught The Eye Of Investors

Moomoo Breakfast US

Jun 22, 2022 07:48

Columns Today's pre-market stock movers: BBIO, LZB, ORA, DOW and more

Gainers:
• $La-Z-Boy (LZB.US)$ +9.3% (In reaction to earnings/guidance)
• $Enanta Pharmaceuticals (ENTA.US)$ +6.7% (ENTA files patent infringement lawsuit against $Pfizer (PFE.US)$)
• $Ikena Oncology (IKNA.US)$ +6.6% (granted Fast Track designation for IK-930)
• $BridgeBio Pharma (BBIO.US)$ +6.4% (Announces Early Positive Data for BBP-812)
• $Krystal Biotech (KRYS.US)$ +5% (submits Biologies License Application to FDA seeking approval of B-V...